atenolol has been researched along with doxazosin in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (27.12) | 18.7374 |
| 1990's | 21 (35.59) | 18.2507 |
| 2000's | 18 (30.51) | 29.6817 |
| 2010's | 4 (6.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Daae, L; Talseth, T; Westlie, L | 2 |
| Boman, K; Jansson, JH; Johansson, B; Nilsson, TK | 1 |
| Lindgren, B | 1 |
| Elkeles, RS; Feher, MD; Gelding, S; Henderson, AD; Poulter, C; Richmond, W; Sever, PS; Wadsworth, J | 1 |
| Bornmyr, S; De Pedis, G; Hulthén, UL; Lecerof, H; Lilja, B | 1 |
| Groppelli, A; Mancia, G; Omboni, S; Parati, G | 1 |
| Daae, LN; Talseth, T; Westlie, L | 1 |
| Christensen, CC; Dathan, R; Dean, S; Searle, M; Westheim, A | 1 |
| Jansen, H | 1 |
| Amery, A; Fagard, R; Lijnen, P; Staessen, J | 2 |
| Baggen, MG; Birkenhäger, JC; Jansen, H; Lammers, R | 1 |
| Amery, A; Fagard, R; Lijnen, P; Lissens, W; Staessen, J | 1 |
| Bautovich, GJ; Fletcher, PJ; Gillin, AG; Horvath, JS; Hutton, BF; Tiller, DJ | 1 |
| Birkeland, S; Grong, K; Kvitting, P; Lekven, J; Westby, J | 1 |
| Cox, DA; Frick, MH; Himanen, P; Huttunen, M; Pitkäjärvi, T; Pörsti, P; Pöyhönen, L; Pyykönen, ML; Reinikainen, P; Salmela, P | 1 |
| Badskjaer, J; Faergeman, O; Jensen, H; Krusell, LR; Ott, P; Storm, TL | 1 |
| Black, H; Nash, DT; Reeves, RL; Schonfeld, G; Weidler, DJ | 1 |
| Daae, L; Talseth, T; Vatle, S; Westlie, L | 1 |
| Guerrasio, E; Mazzola, C | 1 |
| Fioravanti, G; Giorgi, G; Legramante, A; Legramante, JM; Paies, G | 1 |
| Frick, MH; Halttunen, P; Himanen, P; Huttunen, M; Pitkäjärvi, T; Pörsti, P; Pöyhönen, L; Pyykönen, ML; Reinikainen, P; Salmela, P | 1 |
| Baez, MA; Garg, DC; Jallad, NS; Weidler, DJ | 1 |
| Himanen, P; Lehtonen, A; Marniemi, J; Niittymäki, K; Saraste, M | 1 |
| Cox, DA; Leader, JP; Milson, JA; Singleton, W | 1 |
| Faulkner, JK; Himanen, P; Karjalainen, U; Saraste, M | 1 |
| González Maqueda, I | 1 |
| Bellini, G; Bocin, E; Cosenzi, A; Mangiarotti, M; Molino, R; Sacerdote, A | 1 |
| Fahrenbach, MC; Thompson, PD; Yurgalevitch, SM; Zmuda, JM | 1 |
| Andersson, PE; Berne, C; Johansson, J; Lithell, H | 1 |
| Carruthers, SG; Huff, MW; Newman, C; Rabkin, SW; Sim, D | 1 |
| Carruthers, G; Dessain, P; Fodor, G; Newman, C; Palmer, W; Sim, D | 1 |
| Romero-Vecchione, E; Rosa, F; Vasquez, J | 1 |
| Daae, LN; Westlie, L | 1 |
| Andersen, P; Arnesen, H; Herzog, A; Hjermann, I; Holme, I; Seljeflot, I | 1 |
| Andersen, P; Arnesen, H; Aspelin, T; Kierulf, P; Seljeflot, I | 1 |
| Aizawa, Y; Chinushi, M; Furushima, H; Washizuka, T | 1 |
| Anderson, DC; Brown, CA; Hall, JE; Jones, DW; Miller, ME; Wofford, MR | 1 |
| Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F | 1 |
| Diener, HC | 1 |
| Garganeeva, AA; Gavrilova, NV; Tepliakov, AT | 1 |
| Biondi, B; Fazio, S; Lombardi, G; Pagano, L; Palmieri, EA; Pulcrano, M; Rossi, A; Tauchmanova, L | 1 |
| Asai, T; Fujita, H; Kanmatsuse, K; Kushiro, T | 1 |
| Colon, P; Crow, R; Cutler, JA; Davis, BR; Dunn, K; Ellsworth, A; Franklin, S; Furberg, C; Goff, D; Golden, J; Leenen, F; Mohiuddin, S; Papademetriou, V; Piller, LB; Proschan, M | 1 |
| Oguz, A; Uzunlulu, M; Yorulmaz, E | 1 |
| Christian, R; Colon, PJ; Cushman, WC; Einhorn, PT; Ford, CE; Goff, DC; Henriquez, MA; Margolis, KL; Piller, LB; Vidt, DG; Wong, ND; Wright, JT | 1 |
| Barrios, V; Calderon, A; Echarri, R; Escobar, C; Tomás, JP | 1 |
| Eguchi, K; Hoshide, S; Ishikawa, J; Kario, K; Matsui, Y; Pickering, TG; Shibasaki, S; Shimada, K | 1 |
| Eguchi, K; Hoshide, S; Ishikawa, J; Kario, K; Matsui, Y; Shibasaki, S; Shimada, K | 1 |
| Daya, R; Mansfield, BS | 1 |
1 review(s) available for atenolol and doxazosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
40 trial(s) available for atenolol and doxazosin
| Article | Year |
|---|---|
Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up.
Topics: Antihypertensive Agents; Atenolol; Cholesterol; Coronary Disease; Double-Blind Method; Doxazosin; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Norway; Prazosin; Risk Factors; Time Factors | 1991 |
Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Body Weight; Double-Blind Method; Doxazosin; Female; Fibrinolysis; Heart Rate; Humans; Hypercholesterolemia; Hypertension; Male; Plasminogen Inactivators; Prazosin; Randomized Controlled Trials as Topic; Risk Factors; Tissue Plasminogen Activator | 1991 |
Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
Topics: Adrenergic alpha-Antagonists; Aged; Atenolol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Doxazosin; Female; Glucose; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Prazosin | 1990 |
Acute effects of doxazosin and atenolol on smoking-induced peripheral vasoconstriction in hypertensive habitual smokers.
Topics: Adrenergic alpha-Antagonists; Adult; Atenolol; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Plethysmography; Prazosin; Skin; Smoking; Thermography; Ultrasonography; Vascular Resistance; Vasoconstriction | 1990 |
Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition.
Topics: Adrenergic alpha-Antagonists; Adult; Atenolol; Blood Pressure; Doxazosin; Heart Rate; Humans; Hypertension; Prazosin; Single-Blind Method; Smoking | 1990 |
Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Atenolol; Double-Blind Method; Doxazosin; Female; Hemodynamics; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Retrospective Studies; Smoking | 1990 |
Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Prazosin | 1990 |
A long-term study of atenolol and doxazosin in mild and moderate hypertension.
Topics: Adolescent; Adult; Aged; Atenolol; Blood Pressure; Cholesterol; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Prazosin; Risk Factors; Time Factors; Triglycerides | 1990 |
Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Doxazosin; Drug Administration Schedule; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Regression Analysis | 1990 |
Short-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin; Random Allocation; Regression Analysis | 1988 |
Long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Chemical Analysis; Blood Pressure; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Random Allocation; Time Factors | 1989 |
Comparison of doxazosin and atenolol in mild hypertension, and effects on exercise capacity, hemodynamics and left ventricular function.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Physical Exertion; Prazosin; Radionuclide Imaging | 1989 |
Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin; Random Allocation; Time Factors | 1987 |
Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Prazosin | 1987 |
A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Heart Rate; Humans; Hypertension; Lipids; Placebos; Prazosin; Random Allocation | 1987 |
Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Coronary Disease; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin | 1988 |
Doxazosin versus atenolol: a randomized comparison of calculated coronary heart disease risk reduction.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Coronary Disease; Doxazosin; Female; Heart Rate; Humans; Lipids; Male; Middle Aged; Prazosin; Random Allocation; Risk | 1988 |
A comparative study of doxazosin versus atenolol in mild-to-moderate hypertension.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Doxazosin; Electrocardiography; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prazosin | 1988 |
A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Kinetics; Lipids; Male; Middle Aged; Prazosin; Random Allocation | 1986 |
Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin; Random Allocation | 1986 |
Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
Topics: Adult; Aged; Antihypertensive Agents; Apolipoproteins; Atenolol; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Prazosin; Random Allocation; Time Factors; Triglycerides | 1986 |
The antihypertensive effects of doxazosin: a clinical overview.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Kinetics; Male; Metoprolol; Middle Aged; Nadolol; Prazosin; Propanolamines; Random Allocation; Risk; Triglycerides | 1986 |
The pharmacokinetics and pharmacodynamics of doxazosin compared with atenolol during long-term double-blind treatment.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Kinetics; Male; Middle Aged; Prazosin; Random Allocation | 1987 |
Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Carbazoles; Carvedilol; Cholesterol; Doxazosin; Electrocardiography, Ambulatory; Endothelium, Vascular; Ergometry; Female; Fibrinolysis; Heart Rate; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Myocardial Ischemia; Propanolamines; Tissue Plasminogen Activator; Treatment Outcome; Triglycerides | 1994 |
Metabolic effects of atenolol and doxazosin in healthy volunteers during prolonged physical exercise.
Topics: Adipose Tissue; Adult; Analysis of Variance; Atenolol; Blood Chemical Analysis; Blood Glucose; Blood Pressure; Doxazosin; Exercise; Exercise Test; Fatty Acids, Nonesterified; Female; Heart Rate; Humans; Lactates; Lactic Acid; Male; Single-Blind Method | 1995 |
Effect of doxazosin or atenolol on exercise performance in physically active, hypertensive men.
Topics: Adult; Aged; Atenolol; Cross-Over Studies; Double-Blind Method; Doxazosin; Exercise Test; Humans; Hypertension; Male; Middle Aged; Physical Endurance; Physical Exertion; Running | 1995 |
Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
Topics: Adult; Aged; Atenolol; Carbohydrate Metabolism; Double-Blind Method; Doxazosin; Female; Hemodynamics; Humans; Hypertension; Insulin; Lipoproteins; Male; Middle Aged; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-2; Single-Blind Method | 1994 |
Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
Topics: Apolipoproteins E; Atenolol; Blood Pressure; Double-Blind Method; Doxazosin; Humans; Hypertension; Lipids; Lipoproteins | 1994 |
Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group.
Topics: Adult; Aged; Atenolol; Cholesterol; Cholesterol, HDL; Coronary Disease; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors | 1993 |
A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Coronary Disease; Double-Blind Method; Doxazosin; Humans; Hypertension; Lipids; Middle Aged; Risk Factors | 1998 |
Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men.
Topics: Adult; Antihypertensive Agents; Atenolol; Cholesterol, HDL; Doxazosin; Female; Fibrinolysis; Gonadal Steroid Hormones; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Plasminogen Activators | 1998 |
Effects of doxazosin and atenolol on circulating endothelin-1 and von Willebrand factor in hypertensive middle-aged men.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Biomarkers; Blood Pressure; Doxazosin; Endothelin-1; Endothelium; Humans; Hypertension; Male; Middle Aged; Single-Blind Method; von Willebrand Factor | 1999 |
Role of alpha1-blockade in congenital long QT syndrome: investigation by exercise stress test.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Doxazosin; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Propranolol | 2001 |
Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure Monitoring, Ambulatory; Doxazosin; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Prospective Studies; Sympathetic Nervous System | 2001 |
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed | 2002 |
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Treatment Outcome | 2006 |
The effect of carvedilol on metabolic parameters in patients with metabolic syndrome.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Anthropometry; Antihypertensive Agents; Atenolol; Carbazoles; Carvedilol; Cholesterol, HDL; Doxazosin; Drug Administration Schedule; Female; Humans; Hypertension; Lipids; Male; Metabolic Syndrome; Middle Aged; Propanolamines; Prospective Studies; Risk Factors | 2006 |
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthalidone; Clonidine; Double-Blind Method; Doxazosin; Female; Heart Diseases; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Puerto Rico; Reserpine; Treatment Outcome; United States; United States Virgin Islands; White People | 2007 |
Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
Topics: Age Factors; Albuminuria; Antihypertensive Agents; Atenolol; Carotid Artery, Common; Carotid Artery, Internal; Diabetes Mellitus, Type 2; Double-Blind Method; Doxazosin; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Tunica Intima; Tunica Media; Ultrasonography; Ventricular Function, Left | 2008 |
Monitoring of the central pulse pressure is useful for detecting cardiac overload during antiadrenergic treatment: the Japan Morning Surge 1 study.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Biomarkers; Blood Pressure; Blood Pressure Determination; Brachial Artery; Carotid Arteries; Case-Control Studies; Doxazosin; Drug Therapy, Combination; Female; Humans; Hypertension; Japan; Male; Middle Aged; Natriuretic Peptide, Brain | 2008 |
18 other study(ies) available for atenolol and doxazosin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
The cost-benefit approach to pricing new medicines: doxazosin versus beta-blocker treatment in Sweden.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Atenolol; Blood Pressure; Cholesterol; Cost-Benefit Analysis; Doxazosin; Humans; Hypertension; Lipoproteins, HDL; Male; Middle Aged; Prazosin; Sweden | 1990 |
The mode of action of alpha 1-adrenoceptor blockers on blood lipids.
Topics: Animals; Atenolol; Cholesterol, Dietary; Cholesterol, HDL; Cricetinae; Doxazosin; Humans; Lipoprotein Lipase; Mesocricetus; Prazosin; Propranolol; Time Factors; Triglycerides | 1990 |
Effects of doxazosin on lipids, lipoprotein lipases, and cholesterol synthesis in the golden hamster.
Topics: Adrenergic alpha-Antagonists; Animals; Atenolol; Cholesterol; Cholesterol, Dietary; Cricetinae; Doxazosin; Insulin; Lipase; Lipoprotein Lipase; Liver; Male; Mesocricetus; Norepinephrine; Prazosin; Propranolol; Thyroid Hormones; Triglycerides | 1989 |
Does alpha 1-adrenergic blockade influence regional blood flow regulation in hearts with coronary artery occlusion?
Topics: Animals; Atenolol; Cats; Coronary Circulation; Coronary Disease; Doxazosin; Female; Male; Prazosin; Vasodilator Agents | 1989 |
[Direct negative inotropic effect of cocaine in rat ventricle strip].
Topics: Animals; Atenolol; Calcium Channels; Cocaine; Depression, Chemical; Doxazosin; Male; Matched-Pair Analysis; Myocardial Contraction; Rats; Rats, Sprague-Dawley | 1996 |
[Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Aspirin; Atenolol; Atrial Fibrillation; Carotid Artery, Internal; Carotid Stenosis; Chlorthalidone; Clinical Trials as Topic; Diabetes Complications; Diuretics; Doxazosin; Female; Fibrinolytic Agents; Hormone Replacement Therapy; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Life Style; Losartan; Male; Neurology; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pravastatin; Primary Prevention; Risk Factors; Simvastatin; Smoking; Societies, Medical; Stroke | 2003 |
[Effects of monotherapy with an alpha1-adrenoblocker doxazosin and its combination with beta1-adrenoblocker atenolol on hemodynamics, reversible myocardial ischemia in postmyocardial infarction patients with arterial hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Blood Pressure; Data Interpretation, Statistical; Doxazosin; Drug Therapy, Combination; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction | 2003 |
Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning paraga
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Catecholamines; Child; Doxazosin; Drug Therapy, Combination; Electrocardiography; Female; Heart Diseases; Heart Neoplasms; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Para-Aortic Bodies; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Blood Pressure; Cardiomegaly; Doxazosin; Drug Therapy, Combination; Echocardiography; Heart Rate; Hypertension; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; RNA, Messenger | 2005 |
[ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Doxazosin; Drug Therapy, Combination; Follow-Up Studies; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2005 |
Impact of arterial stiffness reduction on urinary albumin excretion during antihypertensive treatment: the Japan morning Surge-1 study.
Topics: Aged; Albuminuria; Ankle Brachial Index; Antihypertensive Agents; Atenolol; Blood Flow Velocity; Brachial Artery; Cohort Studies; Doxazosin; Drug Therapy, Combination; Elasticity; Female; Humans; Hypertension; Male; Pulsatile Flow; Retrospective Studies | 2010 |
Large paraganglioma at the organ of Zuckerkandl.
Topics: Abdominal Pain; Adult; Atenolol; Doxazosin; Female; Humans; Leiomyoma; Magnetic Resonance Imaging; Para-Aortic Bodies; Paraganglioma | 2019 |